PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Summary

The goal of this study is to determine the safety of using PSMA-PET/mpMRI to define radiotherapy targets, while meeting all current planning criteria. This study also intends to determine the feasibility of performing stereotactic body radiation therapy with simultaneous integrated boost on the dominant intra-prostatic lesions while meeting all current planning criteria.

Timeline

Start

2022-11-29

Primary completion

2024-02-07

Completion

2024-02-07

Drugs

Indications